Christopher Bowden, Chief Medical Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 7,100 shares at $50.16 ($356K) on 2020-02-13, disclosed to the SEC on 2020-02-18.
Open-market sale of $356k AGIO by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AGIO | SELL | 2021-06-11 | $3.4M | — | Filing → |
| AGIO | SELL | 2021-06-09 | $1.3M | — | Filing → |
| AGIO | SELL | 2021-04-21 | $1.9M | — | Filing → |